Puma Biotechnology Competitors and Similar CompaniesClear all
ImmunoGen's competitors and similar companies include Oncopeptides.
 ImmunoGen ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. | ||
Founding Date | Founding Date 1981 | Founding Date 2000 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Waltham, US HQ | Locations Stockholm, SE HQ Stockholm, SE Los Altos, US Mountain View, US Waltham, US |
Employees | Employees 277161% increase | Employees 80 |
Valuation ($) | Valuation ($) 8.7 b | Valuation ($) 42.4 m |
Financial | ||
Revenue (est.) | Revenue (est.) $108.8m (FY, 2022) | Revenue (est.) kr71.1m (FY, 2025) |
Cost of goods | Cost of goods $176k (FY, 2022) | Cost of goods kr2.5m (FY, 2025) |
Gross profit | Gross profit $108.6m (FY, 2022) | Gross profit kr72m (FY, 2025) |
Net income | Net income ($222.9m) (FY, 2022) | Net income (kr249.6m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Oncopeptides
HQ
Stockholm, SE
Employees
80
Oncopeptides is a clinical development pharmaceutical company.
View company